Amoxicillin Other names: Amoxycillin

Chemical formula: C₁₆H₁₉N₃O₅S  Molecular mass: 365.404 g/mol  PubChem compound: 33613

Therapeutic indications

Amoxicillin is indicated for:

Acute bacterial sinusitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute bacterial sinusitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute pyelonephritis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute pyelonephritis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Dental abscess with spreading cellulitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Dental abscess and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Asymptomatic bacteriuria in pregnancy

Population group: women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Asymptomatic bacteriuria in pregnancy and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute cystitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute cystitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute otitis media

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute otitis media and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute streptococcal tonsillitis and pharyngitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Streptococcal tonsillitis
Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae
Streptococcus pyogenes
Streptococcus agalactiae
Streptococcus, group C
Streptococcus, group G
Streptococcus, viridans group

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute exacerbations of chronic bronchitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute exacerbation of chronic bronchitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Community acquired pneumonia

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Community acquired pneumonia and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Typhoid and paratyphoid fever

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Typhoid fever
Paratyphoid fever
and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prosthetic joint infection

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Infected arthroplasty and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of endocarditis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure and additionally Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Helicobacter pylori eradication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Helicobacter pylori gastrointestinal tract infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lyme disease

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute bacterial sinusitis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute bacterial sinusitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute otitis media

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute otitis media and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Community acquired pneumonia

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Community acquired pneumonia and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute cystitis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute cystitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute pyelonephritis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute pyelonephritis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Dental abscess with spreading cellulitis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Dental abscess and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute streptococcal tonsillitis and pharyngitis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

at least one of
Streptococcal tonsillitis
Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae
Streptococcus pyogenes
Streptococcus agalactiae
Streptococcus, group C
Streptococcus, group G
Streptococcus, viridans group

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Typhoid and paratyphoid fever

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

at least one of
Typhoid fever
Paratyphoid fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of endocarditis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Preventive procedure and additionally Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lyme disease

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Endocarditis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial meningitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Bacterial meningitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Endocarditis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial meningitis

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Bacterial meningitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: AMOXICILLIN Capsules
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈